| P2093 | author name string | N Miyamoto | |
| | P Massin | |
| | D BenEzra | |
| | F Behar-Cohen | |
| | Y de Kozak | |
| | J C Jeanny | |
| | F Mascarelli | |
| | A Glotin | |
| P2860 | cites work | The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 | Q24302171 |
| | ARPE-19, a human retinal pigment epithelial cell line with differentiated properties | Q28283979 |
| | Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders | Q28646428 |
| | Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization | Q31147566 |
| | Increased expression of placenta growth factor in proliferative diabetic retinopathy. | Q32126116 |
| | Retinal and choroidal neovascularization | Q33980639 |
| | Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. | Q34280300 |
| | Vascular endothelial growth factors and angiogenesis in eye disease | Q35070749 |
| | Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy | Q35102944 |
| | Targets for pharmacological intervention of endothelial hyperpermeability and barrier function | Q35127984 |
| | VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis | Q35299319 |
| | The role of growth factors in the pathogenesis of diabetic retinopathy | Q35906962 |
| | Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma | Q35967211 |
| | Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group | Q39481123 |
| | CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. | Q40683109 |
| | SDF-1 is both necessary and sufficient to promote proliferative retinopathy. | Q40743408 |
| | Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. | Q41091104 |
| | Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril | Q42515185 |
| | A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability | Q42801432 |
| | A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. | Q42826185 |
| | Structural mechanisms of acute VEGF effect on microvessel permeability | Q44298367 |
| | Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells | Q44386990 |
| | Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography | Q44879359 |
| | Serous macular detachment in diabetic cystoid macular oedema | Q45269097 |
| | A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema | Q46695946 |
| | Serum inflammatory markers in diabetic retinopathy | Q46774828 |
| | VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. | Q49101572 |
| | Diabetic retinopathy | Q73511312 |
| | Patterns of diabetic macular edema with optical coherence tomography | Q77893983 |
| | Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors | Q78101810 |
| | VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice | Q78881009 |
| | Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells | Q81449659 |
| P433 | issue | 2 | |
| P304 | page(s) | 461-470 | |
| P577 | publication date | 2006-12-23 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy | |
| P478 | volume | 50 | |